This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $17,025.98 and a completion date of September 22, 2023. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $23,582.96 and is a delivery order contract with a firm fixed price. The contract does not have a set-aside designation, indicating...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price of $1,668.96 and a completion date of July 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price of $7,719.44 and a completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,190.24, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract is a Firm Fixed Price (FFP) Delivery Order, with a completion date of November 29, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.87 firm fixed price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 28, 2023 and was awarded on March 27, 2023. This delivery order is part of a larger $999,999,999...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60s, a medication used in the treatment of chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $1,364.02 and is a firm fixed-price delivery order with a period of performance through July 17, 2024. This contract is not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,364.05, is for the provision of Trelegy Ellipta 100-62.5-25 60s, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract is a firm fixed-price delivery order, with a completion date of May 29, 2024. The contract was not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This is a firm fixed-price delivery order for $5,369.40 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD), with a period of performance through January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $3,757.27 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 60 units of the pharmaceutical product Trelegy Ellipta, which is used to treat chronic obstructive pulmonary disease (COPD). The order has a firm fixed price and an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...